ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Europe
The theme of this year’s ISPOR Europe conference in Barcelona is “Generating evidence towards health and wellbeing”. Sessions will focus on the science, practice, and policies of healthcare value assessment and promote a broader view of health economics and outcomes research (HEOR) that considers the physical, mental, and social health aspects of innovation. At ISPOR Europe, eCOA scientists from Clario will present two scientific posters. Thomas Moll, Ph.D., MBA, will present on the “Study Participant Device Utilization When Offered a Choice Between BYOD Versus Sponsor-Provided” on 19 November between 16:00-19:00 CET. Saima Khakwani, Ph.D., will present an “Exploratory Analysis of Electronic Seizure Diaries: Implications for Diary Design Best Practices” on 20 November between 09:00-11:30 CET.
The ISPOR Real World Evidence Summit will be a co-located event.
Poster session Information:
Poster Session 4
Title: Study Participant Device Utilization When Offered a Choice Between BYOD Versus Sponsor-Provided
Date: Tuesday, 19 November 2024
Poster Session Time: 4:00 p.m. – 7:00 p.m. CET
Discussion Period: 6:00 p.m. – 7:00 p.m. CET
Intro: Choosing between SP and BYOD is a decision that can be driven by various parameters, both for study sponsors (and their CROs) as well as for study participants. The aim of the study was to understand participant preference between SP and BYOD when given the choice and how study and participant characteristics influence that choice.
Speaker
Thomas Moll, Ph.D., MBA
Dr. Moll has been working in the life science industry for almost 20 years and has held various positions both in the CRO industry and within Big Pharma (Eli Lilly). Over the years, he has found himself focusing increasingly on projects in the post-marketing space that require patient experience data for regulatory decision making, be it as a regulatory writer or coordinating large global Phase 4 studies. Since joining Clario as a Scientific Advisor eCOA in 2022, he participates in numerous new initiatives aimed at strengthening the role of Science throughout the eCOA lifecycle to improve data integrity and ultimately patients’ benefit. In addition, he’s passionate about transmitting his knowledge about the wonderful world of drug development to young professionals.
Poster Session 5
Title: Exploratory Analysis of Electronic Seizure Diaries: Implications for Diary Design Best Practices
Date: Wednesday, 20 November 2024
Poster Session Time: 9:00 a.m. – 11:30 a.m. CET
Discussion Period: 9:00 a.m. – 10:00 a.m. CET
Intro: Electronic diaries (eDiaries) that collect seizure events in clinical studies provide insight into the lived experiences of participants with epilepsy. We explored electronic seizure diaries to describe eDiary design, content of eDiaries, and participant compliance to identify elements that can influence data integrity and to help inform diary design best practices for collection of seizure data.
Speaker
Saima Khakwani, MS, MPH
Saima Khakwani is a Scientific Advisor at Clario. Her focus in the team includes diary design best practice such as impact of use of paper and free text in eCOA, patient safety and minimizing risks for commonly implemented PROs and ClinROs and building databases. In her current role, Saima analyzes how our approach to implementing PROs and ClinROs can be tailored to decrease patient burden and increase patient engagement across various therapeutic areas and indications and build knowledge databases. She continues to work on research for improving quality of clinical trial delivery and has authored and co-authored numerous works and publications as a result.